Quality of Life Following Surgical Treatment of Benign Parotid Disease

Overview

Journal Indian J Otolaryngol Head Neck Surg

Publisher Springer

Date 2014 Jan 16

PMID 24427625

Citations 6

Authors

Behcet Gunsoy

Erkan Vuralkan

Nevreste Didem Sonbay

Gokce Simsek

Sibel Alicura Tokgoz

Istemihan Akin

Affiliations

Soon will be listed here.

Abstract

To evaluate the quality of life after surgery for benign neoplastic disease of the parotid gland. Forty-nine patients who underwent surgery for benign parotid disease between January 2004 and December 2008 were included in this retrospective study. EORTC QLQ-C30 and EORTC QLQ-H&N35 questionnaires were used to determine the quality of life. The variables of these questionnaires were compared with age, gender, educational status, histopathologic diagnosis and Frey syndrome. A statistically significant correlation was noted between the female gender and post-surgical pain, sleeplessness and the use of non-steroid anti-inflammatory drugs (p < 0.001). There was a significant difference between age and difficulties in moving the mouth (p < 0.001). Frey syndrome related to social functions, economical difficulties, speech defect, reduced sexuality, and nutritional parameters were found to be statistically significant (p < 0.001). Frey syndrome is the most common complication that affects the quality of life in patients who had parotidectomy due to a benign parotid disease. Therefore, all patients should be informed about Frey syndrome before parotidectomy.

Citing Articles

Long-term outcomes and quality of life following parotidectomy for benign disease.

Plath M, Sand M, Cavaliere C, Plinkert P, Baumann I, Zaoui K Acta Otorhinolaryngol Ital. 2022; 42(3):215-222.

PMID: 35880361 PMC: 9330751. DOI: 10.14639/0392-100X-N1728.

Prospective outcomes following drainless superficial parotidectomy with sternocleidomastoid flap reconstruction.

Melong J, Rigby M, Corsten M, Trites J, Bulter A, Taylor S J Otolaryngol Head Neck Surg. 2020; 49(1):72.

PMID: 33023674 PMC: 7541257. DOI: 10.1186/s40463-020-00472-z.

A retrospective study of 30 basal cell adenomas of the salivary gland in a Brazilian population and literature review.

Cordeiro M, de Freitas Filho S, Servato J, Eisenberg A, Dias F, de Faria P Eur Arch Otorhinolaryngol. 2020; 278(7):2447-2454.

PMID: 32886182 DOI: 10.1007/s00405-020-06331-x.

Post Parotidectomy Quality of Life in Patients with Benign Parotid Neoplasm: A Prospective Study.

Chaudhary V, Rawat D, Tailor M, Verma P, Aseri Y, Singh B Indian J Otolaryngol Head Neck Surg. 2019; 71(Suppl 1):363-368.

PMID: 31741987 PMC: 6848430. DOI: 10.1007/s12070-018-1312-9.

Assessment of the quality of life and performance status in patients with oral submucous fibrosis in central India.

Chole R, Patil R Clujul Med. 2018; 91(2):203-208.

PMID: 29785159 PMC: 5958986. DOI: 10.15386/cjmed-806.

References

Mehle M, Kraus D, Wood B, Benninger M, Eliachar I, Levine H . Facial nerve morbidity following parotid surgery for benign disease: the Cleveland Clinic Foundation experience. Laryngoscope. 1993; 103(4 Pt 1):386-8. DOI: 10.1002/lary.5541030404. View

Beutner D, Wittekindt C, Dinh S, Huttenbrink K, Guntinas-Lichius O . Impact of lateral parotidectomy for benign tumors on quality of life. Acta Otolaryngol. 2006; 126(10):1091-5. DOI: 10.1080/00016480600606731. View

Cavanaugh K, Park A . Postparotidectomy fistula: a different treatment for an old problem. Int J Pediatr Otorhinolaryngol. 1999; 47(3):265-8. DOI: 10.1016/s0165-5876(98)00182-7. View

Gliklich R, Goldsmith T, Funk G . Are head and neck specific quality of life measures necessary?. Head Neck. 1997; 19(6):474-80. DOI: 10.1002/(sici)1097-0347(199709)19:6<474::aid-hed3>3.0.co;2-w. View

Aaronson N, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez N . The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993; 85(5):365-76. DOI: 10.1093/jnci/85.5.365. View

de Bree R, van der Waal I, Leemans C . Management of Frey syndrome. Head Neck. 2007; 29(8):773-8. DOI: 10.1002/hed.20568. View

Gaillard C, Perie S, Susini B, Guily J . Facial nerve dysfunction after parotidectomy: the role of local factors. Laryngoscope. 2005; 115(2):287-91. DOI: 10.1097/01.mlg.0000154735.61775.cd. View

Bova R, Saylor A, Coman W . Parotidectomy: review of treatment and outcomes. ANZ J Surg. 2004; 74(7):563-8. DOI: 10.1111/j.1445-2197.2004.02988.x. View

Patel N, Har-El G, Rosenfeld R . Quality of life after great auricular nerve sacrifice during parotidectomy. Arch Otolaryngol Head Neck Surg. 2001; 127(7):884-8. View

10.

Smith S, Komisar A . Limited parotidectomy: the role of extracapsular dissection in parotid gland neoplasms. Laryngoscope. 2007; 117(7):1163-7. DOI: 10.1097/MLG.0b013e31806009fe. View

11.

Sherman A, Simonton S, Adams D, Vural E, Owens B, Hanna E . Assessing quality of life in patients with head and neck cancer: cross-validation of the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Head and Neck module (QLQ-H&N35). Arch Otolaryngol Head Neck Surg. 2000; 126(4):459-67. DOI: 10.1001/archotol.126.4.459. View

12.

Marshall A, Quraishi S, Bradley P . Patients' perspectives on the short- and long-term outcomes following surgery for benign parotid neoplasms. J Laryngol Otol. 2003; 117(8):624-9. DOI: 10.1258/002221503768199960. View

13.

Casler J, Conley J . Sternocleidomastoid muscle transfer and superficial musculoaponeurotic system plication in the prevention of Frey's syndrome. Laryngoscope. 1991; 101(1 Pt 1):95-100. DOI: 10.1288/00005537-199101000-00019. View

14.

Nitzan D, Kronenberg J, Horowitz Z, Wolf M, Bedrin L, Chaushu G . Quality of life following parotidectomy for malignant and benign disease. Plast Reconstr Surg. 2004; 114(5):1060-7. DOI: 10.1097/01.prs.0000135326.50939.c1. View

15.

Erkan A, Yavuz H, Ozer C, Ozer F, Ozluoglu L . Quality of life after surgery for benign disease of the parotid gland. J Laryngol Otol. 2007; 122(4):397-402. DOI: 10.1017/S0022215107008547. View

16.

Bjordal K, Kaasa S . Psychometric validation of the EORTC Core Quality of Life Questionnaire, 30-item version and a diagnosis-specific module for head and neck cancer patients. Acta Oncol. 1992; 31(3):311-21. DOI: 10.3109/02841869209108178. View

17.

Bjordal K, Hammerlid E, Ahlner-Elmqvist M, de Graeff A, Boysen M, Evensen J . Quality of life in head and neck cancer patients: validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35. J Clin Oncol. 1999; 17(3):1008-19. DOI: 10.1200/JCO.1999.17.3.1008. View

18.

Reilly J, Myssiorek D . Facial nerve stimulation and postparotidectomy facial paresis. Otolaryngol Head Neck Surg. 2003; 128(4):530-3. DOI: 10.1016/S0194-59980300089-5. View

19.

McGurk M, Thomas B, Renehan A . Extracapsular dissection for clinically benign parotid lumps: reduced morbidity without oncological compromise. Br J Cancer. 2003; 89(9):1610-3. PMC: 2394403. DOI: 10.1038/sj.bjc.6601281. View

20.

Ware Jr J, Sherbourne C . The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992; 30(6):473-83. View